openPR Logo
Press release

AbboMax Introduces Antibody Panels for Bcell and Tcell Lymphoma

08-05-2019 01:44 PM CET | Health & Medicine

Press release from: AbboMax

AbboMax has developed the panels of antibodies to study lymphoma. Lymphoma is a malignant transformation of either B or T cells or their subtypes. The B-cell lymphomas are types of lymphoma affecting B cells. T-cell lymphomas are lymphomas that affect T cells. AbboMax, Inc. has been developing & manufacturing immunoassay reagents for many years in California. It specializes in high-quality services and products focusing on antibody and assay development, including polyclonal, phosphospecific antibodies, IHC grade monoclonal antibodies.

San Jose, California, United States., July 31, 2019 -- AbboMax, Inc has developed the panels of antibodies to study B- and T-cell lymphomas. Lymphoma is a cancer of the lymphatic system, it is a group of cancers that develop from lymphocytes.

The lymphatic system includes the lymph nodes, spleen, thymus gland and bone marrow. There are many subtypes of lymphomas. All lymphoma subtypes combined are the seventh most common cancer in the United States. The two main categories of lymphomas are Hodgkin’s lymphomas (HL) and the non-Hodgkin’s lymphomas (NHL). Lymphoma is a malignant transformation of either B or T cells or their subtypes.

The B-cell lymphomas are types of lymphoma affecting B cells. T-cell lymphomas are lymphomas that affect T cells.

B-Cell lymphoma panel includes antibodies against:

CD19, CD20, CD22, CD45, CD45RO, CD79a, CD10, Bcl-2, Bcl-2a, Bcl-6.

T-Cell lymphoma panel includes antibodies against:

CD2, CD3, CD3zeta, CD4, CD5, CD7, CD8, CD8a, CD10, CD45, CD45RO.

Lymphoma related:
MHCII (HLA-DP and DR), CD40, CD56, CXCR3, Cyclin D1, Bcl-10, Bcl-w, Bcl-X.

About AbboMax:
AbboMax, Inc. has been developing & manufacturing high performance immunoassay reagents for many years in California. It specializes in high-quality services and products focusing on antibody and assay development, including polyclonal, phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services.

Please explore more information at: www.abbomax.com
Contact us: info@abbomax.com Tel: 408-573-1898 Fax: 408-573-1858 San Jose, California
By Natasha Raysberg, Ph.D.

Contact:
Natasha Raysberg
AbboMax
2528 Qume Dr #8,
San Jose, CA 95131, USA
1 408-573-1898
sales@abbomax.com
http://www.abbomax.com

AbboMax, Inc. has been developing & manufacturing high performance immunoassay reagents for many years in California. It specializes in high-quality services and products focusing on antibody and assay development, including polyclonal, phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AbboMax Introduces Antibody Panels for Bcell and Tcell Lymphoma here

News-ID: 1816962 • Views:

More Releases for CD4

T Cell Surface Glycoprotein CD4 Market Witness Stunning Growth By 2028 | Biotest …
T Cell Surface Glycoprotein CD4 Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report answers questions on the current and future technological advancements and development. It delivers an analysis of main manufactures and geographic regions. The global T Cell Surface Glycoprotein CD4 market is segmented by company, region (country), type, application, players, stakeholders, and others. The report includes the opportunities and encounters
T Cell Surface Glycoprotein CD4 Market Pegged for Robust Expansion by 2027 | San …
With the help of this extensive market research, key players can easily achieve a prominent position in the industry. It also shows the global implications of COVID-19 on different sectors and countries as well as how it has created havoc in the entire county by bringing down the economy of every sector. In addition, this research illuminates a few crucial areas that will impact the all-inclusive market's liquidity position. It
Idiopathic CD4+ Lymphocytopenia Market 2021-28 Healthcare Need and Demand with N …
Idiopathic CD4+ T cell lymphocytopenia (ICL) is a rare and heterogeneous clinical syndrome that is defined by persistent CD4+ T cell lymphopenia in the absence of infection with human immunodeficiency virus (HIV)-1 or any other cause of immunodeficiency. ICL is a heterogeneous cellular immune deficiency condition, of unknown aetiology, diagnosed typically in middle age, usually after an opportunistic infection and characterized by a low CD4 cell count that is unexplained by
T Cell Surface Glycoprotein CD4 Market Economic Forecasting By 2026 | Top Key Ve …
The T Cell Surface Glycoprotein CD4 Market report includes overview, which interprets value chain structure, industrial environment, regional analysis, applications, market size, and forecast. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes in market conditions. The rapidly changing market scenario and initial and future assessment of the
CD4 Market : Spectator Steady Growth By 2026 According To Expert Reviews & Analy …
segments such as Type, Application, Sales, Growth, Comprises details of companies manufacturing field, production volume, capacities, value chain, product specifications, raw material sourcing strategies, concentration rate, organizational structure, and distribution channel. The research is a precise offset bridging both qualitative and quantitative data of CD4(Antibody) market. The study provides historical data to compare for evolving Sales, Revenue, Volume, Value of 2014 to 2019 and forecasted till 2026. It becomes
CD4 Market 2019 Trends, Size, Share, Growth Insight, Competitive Analysis, Segme …
The most advanced study released by AMR on the CD4(Antibody) market comprising key market segments such as Type, Application, Sales, Growth, Comprises details of companies manufacturing field, production volume, capacities, value chain, product specifications, raw material sourcing strategies, concentration rate, organizational structure, and distribution channel. The research is a precise offset bridging both qualitative and quantitative data of CD4(Antibody) market. The study provides historical data to compare for evolving